Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
第一作者:
Gale,Smith
第一单位:
Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: gsmith@novavax.com.
作者:
医学主题词
动物(Animals);抗体, 中和(Antibodies, Neutralizing);抗体, 病毒(Antibodies, Viral);雪貂(Ferrets);血凝集抑制试验(Hemagglutination Inhibition Tests);血凝素类(Hemagglutinins);流感病毒A型, H1N1亚型(Influenza A Virus, H1N1 Subtype);流感病毒A型, H3N2亚型(Influenza A Virus, H3N2 Subtype);流感疫苗(Influenza Vaccines);小鼠(Mice);纳米粒子(Nanoparticles)
DOI
10.1016/j.vaccine.2017.08.021
PMID
28844407
发布时间
2022-03-30
- 浏览6
Vaccine
5366-5372页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



